VENDOR COMPARISON

Limitless Life Nootropics vs Polaris Peptides

Independent side-by-side comparison across the 4 peptides both vendors sell. Composite scores, lab quality, and verified pricing.

Limitless Life Nootropics

Research
B
Score
6.8
Peptides
14
Tests
58

14 peptides covered with 58 lab tests. BPC-157 averages 6.6 across 6 tests with consistency penalty triggered.

Limitless Life Nootropics full review →

Polaris Peptides

Research
B+
Score
7.6
Peptides
9
Tests
97

9 peptides with 97 lab tests. Tirzepatide and PT-141 grade A; Retatrutide drops to D due to wider score variance.

Polaris Peptides full review →

Side-by-side breakdown

PEPTIDE LIMITLESS LIFE NOOTROPICS POLARIS PEPTIDES WINNER
Ipamorelin
7.2 B (4 tests)
8.0 B+ (5 tests)
Polaris Peptides
GHK-Cu
6.5 B (5 tests)
8.8 B+ (8 tests)
Polaris Peptides
BPC-157
6.4 B (6 tests)
5.4 C (11 tests)
Limitless Life Nootropics
Semaglutide
6.4 B (5 tests)
6.9 B (16 tests)
Polaris Peptides
Tirzepatide
(not sold)
8.8 B+ (15 tests)
Polaris Peptides only
Retatrutide
(not sold)
7.3 B (26 tests)
Polaris Peptides only

Which to choose

Across the 4 peptides both vendors sell, Limitless Life Nootropics scores higher on 1, Polaris Peptides scores higher on 3, and 0 are within 0.3 points (effectively tied). Polaris Peptides additionally sells Tirzepatide, Retatrutide; Limitless Life Nootropics does not.

Choose Limitless Life Nootropics for: BPC-157.

Choose Polaris Peptides for: Ipamorelin, GHK-Cu, Semaglutide.

Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.

Full profiles: Limitless Life Nootropics review · Polaris Peptides review